Cartography Biosciences Advances Strategic Oncology Collaboration with Gilead’s First Option Target Exercise

AI Briefing

• – Cartography Biosciences and Gilead Sciences exercise collaboration on oncology target, marking a key milestone in their partnership. Gilead to exclusively license a novel oncology target. The option exercise validates the success of Cartography's proprietary ATLAS and SUMMIT platforms.